glucagon has been researched along with methotrexate in 6 studies
| Studies (glucagon) | Trials (glucagon) | Recent Studies (post-2010) (glucagon) | Studies (methotrexate) | Trials (methotrexate) | Recent Studies (post-2010) (methotrexate) |
|---|---|---|---|---|---|
| 26,039 | 1,498 | 3,054 | 41,593 | 5,666 | 11,969 |
| Protein | Taxonomy | glucagon (IC50) | methotrexate (IC50) |
|---|---|---|---|
| Thymidylate synthase | Escherichia coli | 1.8 | |
| nuclear receptor coactivator 3 isoform a | Homo sapiens (human) | 0.211 | |
| Toll-like receptor 4 | Homo sapiens (human) | 1.04 | |
| Fatty-acid amide hydrolase 1 | Mus musculus (house mouse) | 0.08 | |
| Dihydrofolate reductase | Homo sapiens (human) | 0.0522 | |
| Dihydrofolate reductase | Mus musculus (house mouse) | 0.0331 | |
| Dihydrofolate reductase | Bos taurus (cattle) | 0.0348 | |
| Dihydrofolate reductase | Gallus gallus (chicken) | 0.0545 | |
| Dihydrofolate reductase | Enterococcus faecium | 0.0014 | |
| Dihydrofolate reductase | Lacticaseibacillus casei | 0.0138 | |
| Thymidylate synthase | Homo sapiens (human) | 0.343 | |
| 5-hydroxytryptamine receptor 2C | Rattus norvegicus (Norway rat) | 0.0147 | |
| Thymidylate synthase | Escherichia coli K-12 | 0.0181 | |
| Dihydrofolate reductase | Escherichia coli K-12 | 0.1529 | |
| Bifunctional dihydrofolate reductase-thymidylate synthase | Plasmodium falciparum K1 | 0.084 | |
| Folate receptor beta | Homo sapiens (human) | 0.1585 | |
| 5-hydroxytryptamine receptor 2A | Rattus norvegicus (Norway rat) | 0.0011 | |
| Cytochrome P450 11B1, mitochondrial | Bos taurus (cattle) | 0.0012 | |
| Folate receptor alpha | Homo sapiens (human) | 0.2263 | |
| Dihydrofolate reductase | Pneumocystis carinii | 0.0717 | |
| Histidine decarboxylase | Rattus norvegicus (Norway rat) | 0.0014 | |
| Trifunctional purine biosynthetic protein adenosine-3 | Homo sapiens (human) | 0.01 | |
| Bifunctional purine biosynthesis protein ATIC | Homo sapiens (human) | 0.01 | |
| Delta-type opioid receptor | Rattus norvegicus (Norway rat) | 0.003 | |
| Mu-type opioid receptor | Rattus norvegicus (Norway rat) | 0.003 | |
| Kappa-type opioid receptor | Rattus norvegicus (Norway rat) | 0.003 | |
| Reduced folate transporter | Homo sapiens (human) | 0.012 | |
| Dihydrofolate reductase | Mycobacterium tuberculosis H37Rv | 0.0174 | |
| Folylpolyglutamate synthase, mitochondrial | Homo sapiens (human) | 3.2 | |
| Bifunctional dihydrofolate reductase-thymidylate synthase | Toxoplasma gondii | 0.0547 | |
| Bifunctional dihydrofolate reductase-thymidylate synthase | Trypanosoma cruzi | 0.11 | |
| Dihydrofolate reductase | Bacillus anthracis | 0.0136 | |
| Dihydrofolate reductase | Rattus norvegicus (Norway rat) | 0.0047 | |
| Proton-coupled folate transporter | Homo sapiens (human) | 0.1207 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (50.00) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Belousova, AK | 1 |
| Lin, MS; Winchell, HS | 1 |
| Bracht, A; Ishii-Iwamoto, EL; Nascimento, EA; Yamamoto, NS | 1 |
| Abad, LW; Dinarello, CA; Dolnikowski, G; Hartman, WJ; Lundgren, N; Rall, LC; Rosen, CJ; Roubenoff, R | 1 |
| KEIDAN, SE | 1 |
| Eaton, P; Rudyk, O | 1 |
1 review(s) available for glucagon and methotrexate
| Article | Year |
|---|---|
[Molecular basis of the relation between the cytotoxic effect of antineoplastic compounds and the cell cycle phase].
Topics: Adenocarcinoma; Adrenocorticotropic Hormone; Alkylating Agents; Androgens; Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Culture Techniques; Cyclic AMP; Dactinomycin; DNA Replication; DNA, Neoplasm; Estrogens; Fluorouracil; Glucagon; Glucocorticoids; Mathematics; Methotrexate; Mitosis; Molecular Biology; Neoplasm Transplantation; Neoplasms, Experimental; Receptors, Drug; RNA, Neoplasm; Sarcoma, Experimental | 1972 |
5 other study(ies) available for glucagon and methotrexate
| Article | Year |
|---|---|
Kinetics of amino acid transport across bone marrow cell membranes.
Topics: Amino Acids; Animals; Biological Transport, Active; Bone Marrow; Bone Marrow Cells; Carbon Isotopes; Cell Membrane; DNA; Dogs; Extracellular Space; Glucagon; Glutamates; Histidine; Imidazoles; Insulin; Kinetics; Methionine; Methotrexate; Models, Biological; Serine; Time Factors; Tryptophan | 1970 |
Naproxen inhibits hepatic glycogenolysis induced by Ca(2+)-dependent agents.
Topics: Animals; Calcium; Glucagon; Liver; Liver Glycogen; Male; Methotrexate; Naproxen; Phenylephrine; Rats; Rats, Wistar | 1995 |
Protein metabolism in rheumatoid arthritis and aging. Effects of muscle strength training and tumor necrosis factor alpha.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antirheumatic Agents; Arthritis, Rheumatoid; Exercise; Female; Glucagon; Growth Hormone; Humans; Leucine; Male; Methotrexate; Middle Aged; Proteins; Time Factors; Tumor Necrosis Factor-alpha | 1996 |
PROLONGED REMISSION IN ACUTE LEUKAEMIA.
Topics: Blood Transfusion; Bone Marrow Cells; Bone Marrow Examination; Child; Diabetes Mellitus; Glucagon; Humans; Leukemia; Mercaptopurine; Methotrexate; Prednisolone; Prognosis; Toxicology; Triamcinolone | 1964 |
Examining a role for PKG Iα oxidation in the pathogenesis of cardiovascular dysfunction during diet-induced obesity.
Topics: Animals; Aorta; Carmustine; Cattle; Cyclic GMP-Dependent Protein Kinase Type I; Diet, High-Fat; Endothelial Cells; Gene Expression Regulation; Glucagon; Hypertension; Leptin; Methotrexate; Mice; Myocytes, Smooth Muscle; Nitric Oxide Synthase Type III; Obesity; Oxidation-Reduction; Oxidative Stress; Reactive Oxygen Species; Resistin; Signal Transduction; Sugar Acids; Uncoupling Agents | 2017 |